China SXT Pharmaceuticals, Inc.
SXTC
$2.29
$0.7144.94%
NASDAQ
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 61.47% | 61.47% | -30.50% | -30.50% | 284.60% |
| Total Receivables | 25.34% | 25.34% | -14.53% | -14.53% | -84.16% |
| Inventory | 173.28% | 173.28% | 40.20% | 40.20% | -15.30% |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 68.49% | 68.49% | -- | -- | -71.86% |
| Total Current Assets | 62.93% | 62.93% | -27.09% | -27.09% | 9.19% |
|
|
|||||
| Total Current Assets | 62.93% | 62.93% | -27.09% | -27.09% | 9.19% |
| Net Property, Plant & Equipment | -58.58% | -58.58% | -55.48% | -55.48% | -21.09% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -29.33% | -29.33% | -31.54% | -31.54% | -26.71% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -4.89% | -4.89% | -- |
| Total Assets | 112.49% | 112.49% | -21.75% | -21.75% | -34.23% |
|
|
|||||
| Total Accounts Payable | 26.35% | 26.35% | -7.14% | -7.14% | -15.71% |
| Total Accrued Expenses | -17.33% | -17.33% | -8.68% | -8.68% | 32.14% |
| Short-term Debt | 199.40% | 199.40% | -61.06% | -61.06% | 164.04% |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -47.96% | -47.96% | 20.61% | 20.61% | -79.45% |
| Total Finance Division Other Current Liabilities | 6.45% | 6.45% | -5.44% | -5.44% | -1.44% |
| Total Other Current Liabilities | 6.45% | 6.45% | -5.44% | -5.44% | -1.44% |
| Total Current Liabilities | 70.26% | 70.26% | -38.59% | -38.59% | 26.17% |
|
|
|||||
| Total Current Liabilities | 70.26% | 70.26% | -38.59% | -38.59% | 26.17% |
| Long-Term Debt | 8.16% | 8.16% | -0.68% | -0.68% | -- |
| Short-term Debt | 199.40% | 199.40% | -61.06% | -61.06% | 164.04% |
| Capital Leases | -10.83% | -10.83% | -28.43% | -28.43% | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 67.82% | 67.82% | -38.12% | -38.12% | 30.44% |
|
|
|||||
| Common Stock & APIC | 9.93% | 9.93% | 8.67% | 8.67% | 13.86% |
| Retained Earnings | 18.51% | 18.51% | -14.34% | -14.34% | -82.21% |
| Treasury Stock & Other | 44.16% | 44.16% | -419.13% | -419.13% | -30.72% |
| Total Common Equity | 196.18% | 196.18% | -5.18% | -5.18% | -65.91% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 196.18% | 196.18% | -5.18% | -5.18% | -65.91% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 196.18% | 196.18% | -5.18% | -5.18% | -65.91% |
|
|
|||||